Lumivive Wellness GLP-1 Program

Sermorelin

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), corresponding to the GHRH (1-29) fragment. It is studied in clinical practice for its interaction with GHRH-receptor signaling and the secretagogue regulation of growth hormone release from the pituitary. In clinical settings, Sermorelin is studied as a GHRH analog in models of the somatotropic (GH/IGF-1) axis, endocrine signaling, and metabolic regulation. Unlike direct growth hormone, GHRH analogs are studied for their action on endogenous GH-secretory signaling pathways, making Sermorelin a common subject of endocrine and metabolic peptide studies. Key Clinical Highlights Studied as a GHRH analog for endogenous growth-hormone secretagogue signaling Investigated for GHRH-receptor interaction and somatotropic-axis studies Examined in models of metabolic and endocrine regulation Studied in clinical literature for cellular-repair and tissue-signaling pathways A frequent subject of endocrine and metabolic peptide studies Product Specifications Form: Lyophilized powder Vial Size: 10 mg Purity: ≥98% (HPLC tested) Storage: Store dry at 2-8°C. After reconstitution, refrigerate and use within 20 days. Compounded by a licensed U.S. pharmacy and dispensed only under a prescription from our clinic physician.

$59.00